MYC and small cell lung carcinoma: MYC amplification is thought to drive SCLC-A switching to SCLC-N and SCLC-Y, as GEMMs with Trp53/Rb1 KO and hyperactive MYC develop invasive tumors of these other subtypes from primary SCLC-A tumors [17,18].